[Clinical analysis of scimitar syndrome in 6 pediatric patients]

J Yang1, W W Ding, R Wang

  • 1Pediatric Cardiovascular Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Insights

Scimitar syndrome (SS) presents varied clinical features, from asymptomatic to severe pulmonary hypertension. Early diagnosis and tailored treatment, especially for complex cases, are crucial for improving outcomes in children with SS.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiovascular Imaging

Background:

  • Scimitar syndrome (SS) is a rare congenital anomaly characterized by anomalous pulmonary venous connection.
  • Understanding its diverse clinical spectrum and associated malformations is essential for effective management.

Observation:

  • This study analyzed 6 pediatric SS cases, revealing varied presentations from infant type with severe pulmonary hypertension to asymptomatic adult type.
  • Imaging confirmed anomalous venous drainage and identified frequent co-occurring cardiovascular, vascular, and spinal malformations.

Findings:

  • Infant SS cases exhibited recurrent respiratory infections and growth retardation, with two developing severe pulmonary hypertension.
  • Complex SS cases often involved atrial septal defects, vascular anomalies, and tracheospinal malformations.
  • One patient died from pulmonary hypertension crisis, highlighting the critical nature of this complication.

Implications:

  • Early diagnosis of scimitar syndrome is vital, particularly in isolated cases with subtle symptoms.
  • Combination therapy and timely surgical or interventional treatment significantly improve prognosis in complex SS.
  • Prompt management of pulmonary hypertension in SS is critical to prevent early mortality.

Related Concept Videos

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Here, we present a protocol for the examination of oral Candida infection in patients with primary Sjögren's syndrome, which can be used for timely treatment and, thereafter, avoiding related complications.
1.9K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Continuous 12-lead electrocardiographic (ECG) monitoring can identify transient myocardial ischemia, even when asymptomatic, among patients with suspected acute coronary syndrome (ACS). In this article we describe our method for initiating patient monitoring using a Holter device, downloading the ECG data for off-line analysis, and how to utilize the ECG software to identify transient...
24.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

This article provides comprehensive step-by-step instructions for the acquisition of whole-body 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) PET/MRI scans for cancer staging of pediatric patients. The protocol was developed for children above 6 years, or old enough to comply with breath-hold instructions, but can be used for general anesthesia patients as...
15.2K